PatientsVille.com LogoPatientsVille.com

Drug Toxicity | Regional Data Exchange to Improve Medication Safety

Drug Toxicity research study

What is the primary objective of this study?

Medication reconciliation, a process by which a provider obtains and documents a thorough medication history with specific attention to comparing current and previous medication use, can prevent medication-related errors and harm. The aims of this study are: 1) To adapt medication reconciliation to include information from a computerized regional health information exchange (RHIO) in the Bronx, 2) To conduct a trial of the adapted medication reconciliation process and examine effects on medication errors, harm, and hospital costs, and 3) To identify factors that are barriers to adoption of the RHIO tool by James J. Peters (Bronx) VA providers. Findings from this project will provide an understanding of the effect of the RHIO tool on reducing harmful VA and non-VA medication use. It will also provide information on the feasibility of incorporating RHIO tool use into every day work flow for pharmacists and physicians.

Who is eligible to participate?

Inclusion Criteria: - Veterans admitted to James J. Peters VA hospital units 6B, 7B, 7C, or 8B or seen as outpatients in the Geriatrics Primary care clinic, who have an identity match in the Bronx RHIO, who consent to participate in the Bronx RHIO, and who stay on the unit at least 24 hours Exclusion Criteria: - Cannot be transferred from another James J. Peters VA hospital unit

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Drug Toxicity

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Other:HIE-Enhanced Medication ReconciliationMedication reconciliation enhanced by regional health information exchange, implemented by a pharmacist

Other:Optimal Medication Reconciliation without HIEMedication reconciliation implemented by a pharmacist without regional health information exchange

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

HIE-Enhanced Medication ReconciliationHealth Information Exchange (HIE)-Enhanced Medication Reconciliation for Veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)

Optimal Medication Reconciliation without HIEOptimal Medication Reconciliation without Health Information Exchange (HIE) for Veterans admitted to James J Peters VA hospital units 6B, 7B, 7C, and 8B (each unit crossing over between intervention and control every 3-4 months)

Pilot HIE-Enhanced Outpatient Medication ReconciliationHealth Information Exchange (HIE)-Enhanced Medication Reconciliation for Veterans seen as outpatients in Geriatrics Primary care clinic

Study Status

Completed

Start Date: February 2012

Completed Date: June 2016

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Transition Drug Risk

Secondary Outcome: Adverse Drug Events

Study sponsors, principal investigator, and references

Principal Investigator: Kenneth S Boockvar, MD MS

Lead Sponsor: VA Office of Research and Development

Collaborator: University of Victoria

More information:https://clinicaltrials.gov/show/NCT01239121

Hung WW, Morano B, Moodhe N, Boockvar K. Regional Health Information Organization (RHIO): its potential uses to improve veteran health care. Federal practitioner : for the health care professionals of the VA, DoD, and PHS. 2011 Jan 1; 28(3):33-36.

Discuss Medications